Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer von Reddy, S M, Sadim, M, Li, J, Yi, N, Agarwal, S, Mantzoros, C S, Kaklamani, V G

Volltext

Behçet's Disease von Kaklamani, Virginia G., Vaiopoulos, George, Kaklamanis, Phaedon G.

Volltext

Dietary Fat and Carbohydrates Are Independently Associated With Circulating Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor–Binding Protein 3 Concentrations in Healthy... von KAKLAMANI, V. G, LINOS, A, KAKLAMANI, E, MARKAKI, L, KOUMANTAKI, Y, MANTZOROS, C. S

Volltext

Treatment of Behçet's disease—An update von Kaklamani, Virginia G., Kaklamanis, Phaedon G.

Volltext

A pilot study of cabergoline for the treatment of metastatic breast cancer von Costa, Ricardo, Santa-Maria, C. A., Scholtens, D. M., Jain, S., Flaum, L., Gradishar, W. J., Clevenger, C. V., Kaklamani, V. G.

Volltext

Effect of birth weight and maternal smoking on cord blood leptin concentrations of full-term and preterm newborns von MANTZOROS, C. S, VARVARIGOU, A, KAKLAMANI, V. G, BERATIS, N. G, FLIER, J. S

Volltext

Could nicotine be beneficial for Behçet's disease? von Kaklamani, V G, Markomichelakis, N, Kaklamanis, P G

Volltext

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer von Sparano, Joseph A, Gray, Robert J, Makower, Della F, Pritchard, Kathleen I, Albain, Kathy S, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Goetz, Matthew P, Olson, John A, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Paik, Soonmyung, Wood, William C, Ravdin, Peter M, Keane, Maccon M, Gomez Moreno, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Berenberg, Jeffrey L, Abrams, Jeffrey, Sledge, George W

Volltext

Clinical features of juvenile Adamantiades-Behçet's disease in Greece von VAIOPOULOS, G, KAKLAMANI, V. G, MARKOMICHELAKIS, N, TZONOU, A, MAVRIKAKIS, M, KAKLAMANIS, P

Volltext

Evaluating the Role of Extended Aromatase Inhibitor Therapy in Early Hormone-Positive Breast Cancer von Vyas, O. H., Kaklamani, V. G.

Volltext

Abstract P6-17-26: Care 001: multi-center randomized open-label phase II trial of neoadjuvant trastuzumab emtansine (T-DM1) in combination with lapatinib and nab-paclitaxel compare... von Creamer, SL, Patel, TA, Ensor, JE, Rodriguez, AA, Niravath, PA, Darcourt, JG, Kaklamani, VG, Meisel, JL, Li, X, Zhao, J, Kuhn, JG, Rosato, RR, Qian, W, Belcheva, A, Boone, T, Chang, J

Volltext

Assessment of physician responses to abnormal results of bone densitometry studies von Economides, P A, Kaklamani, V G, Karavas, I, Papaioannou, G I, Supran, S, Mirel, R D

Volltext

A regional subgroup analysis of a multinational, double-blind, randomized, placebo-controlled, phase IIb study evaluating sorafenib (SOR) with paclitaxel (PAC) in patients (pts) wi... von Sahoo, T. P., Kaklamani, V. G., Lokanatha, D., Raina, V., Bondarde, S., Jain, M., Schwartzberg, L. S., Gradishar, W. J.

Volltext

Abstract GS4-07: Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial von Albain, K, Gray, RJ, Sparano, JA, Makower, DF, Pritchard, KI, Hayes, DF, Geyer, CE, Dees, EC, Goetz, MP, Olson, JA, Lively, T, Badve, SS, Saphner, TJ, Wagner, LI, Whelan, TJ, Ellis, MJ, Paik, S, Wood, WC, Ravdin, PM, Keane, MM, Gomez, HL, Reddy, PS, Goggins, TF, Mayer, IA, Brufsky, AM, Toppmeyer, DL, Kaklamani, VG, Berenberg, JL, Abrams, J, Sledge, GW

Volltext

TGFBR16A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies von Kaklamani, Virginia G, Hou, Nanjiang, Bian, Yiansong, Reich, Jennifer, Offit, Kenneth, Michel, Loren S, Rubinstein, W S, Rademaker, Alfred, Pasche, Boris

Volltext

Abstract P6-09-09: Evaluation of tumor infiltrating lymphocytes (TILs) and their association with homologous recombination deficiency and BRCA1/2 mutation status in triple-negative... von Telli, ML, Badve, S, Vinayak, S, Silver, DP, Isakoff, SJ, Kaklamani, VG, Gradishar, WJ, Stearns, V, Connolly, RM, Ford, JM, Adams, S, Garber, JE, Evans, B, Timms, K, Wenstrup, R, Richardson, AL

Volltext

Combined genetic assessment of transforming growth factor-β signaling pathway variants may predict breast cancer risk von KAKLAMANI, Virginia G, BADDI, Lisa, OSTRER, Harry, MICHEL, Loren S, HUANG, Helen, YU CHEN, AHSAN, Habibul, OFFIT, Kenneth, PASCHE, Boris, JUNJIAN LIU, ROSMAN, Diana, PHUKAN, Sharbani, BRADLEY, Ciaran, HEGARTY, Chris, MCDANIEL, Bree, RADEMAKER, Alfred, ODDOUX, Carole

Volltext

Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV) von Hudis, C., Tauer, K. W., Hermann, R. C., Makari-Judson, G., Isaacs, C., Beck, J. T., Kaklamani, V. G., Stepanski, E. J., Rugo, H. S., Wang, W., Bell-McGuinn, K. M., Chera, H., Zaugg, B., Ro, S. K., Li, S., Schwartzberg, L. S.

Volltext

Increased HER2 expression in women with recurrent ER positive breast cancer von Kaklamani, V. G., Cicconi, J., Gradishar, W., Willey, E., Diaz, L., Rademaker, A., O'Regan, R.

Volltext

TGF-beta polymorphisms in head and neck and lung cancer von Kaklamani, V. G., Oikonomopoulou, C., O’Keeffe, P., Oikonomopoulou, P., Sadim, M., Pasche, B., Argiris, A.

Volltext